Insmed announces positive results from Phase III arise study of ARIKAYCE
Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score
Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score
This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
The cognitively operated system is a mother patent invention, first launched in India
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Subscribe To Our Newsletter & Stay Updated